TR40 Sterilizing Filtration of Gases a Comparison WithTR26 Sterilizing Filtration of Liquids
Current Topics in Sterilizing Filtration
-
Upload
steven-lambert -
Category
Documents
-
view
18 -
download
3
description
Transcript of Current Topics in Sterilizing Filtration
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
1
Current Topics in Sterilizing Filtration
ISPE Tampa ConferenceF b 22 23 2010February 22-23, 2010Michael Moussourakis
Technical ManagerPall Life Sciences
Current Topics in Sterilizing Filtration
• Pre-use Integrity Testingg y g• Single Use Filtration Systems• Serial / Double / Redundant Filtration
2
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
2
Filter Integrity Testing
• Pre-use• Pre-sterilization• Post-sterilization
• Post-use
3
Definition of Integrity
• Unimpaired, soundUnimpaired, sound• Complete, entire• Whole, undamaged
4
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
3
Purpose of Integrity Tests
• Confirms integrity of filter assemblyCorrect grade membrane• Correct grade membrane
• Proper installation of element or cartridge(s) in capsule or housing
• Absence of leaks and damage• Confirms process filter is comparable to
filters in core validation study (val’n guide)
5
filters in core validation study (val n guide)• Predicts validated bacterial retention
Integrity Tests do not measure the pore size of high area filter cartridges
Pre-use Integrity Testing
• Filter manufacturer• Manufacturing release test (100%)
• Confirms integrity prior to shipping, handling, installation and sterilization
• User integrity testing• Pre-sterilization
• Confirms integrity after shipping
6
• Confirms integrity after shipping, handling, and installation
• Post-sterilization• Confirms integrity after sterilization and
immediately prior to use
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
4
FDA Guidance for Industry –Sterile Drug Products Produced bySterile Drug Products Produced by Aseptic Processing – Current Good Manufacturing Practice, September, 2004
“Integrity testing of the filter(s) can be f d i t i d
7
performed prior to processing, and should be routinely performed post-use.
EC Guide to GMP - Revision to Annex I - Manufacture of Sterile Medicinal ProductsRevised Feb, 2008
8
Effective March, 2009
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
5
Filtration Of Medicinal Products Which Cannot Be Sterilised In Their Final Container
113. The integrity of the sterilised filter should be113. The integrity of the sterilised filter should be
verified before use and should be confirmed
immediately after use by an appropriate
method such as a bubble point, diffusive flow
or pressure hold test
9
or pressure hold test.
Rationale for Post-sterilization / Pre-use IT
• Confirms integrity after shipping, g y pp g,handling, installation and sterilization• Risk of loss / rework of product if post-
use failure • Recommended by filter
manufacturers
10
manufacturers• Aids in failure analysis, root cause
determination and corrective and preventative action (CAPA)
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
6
Rationale againstPost-sterilization / Pre-use IT
• Filter manufacturer’s release integrity test g yshowed no defects
• User’s installation test confirms absence of assembly leaks or damage
• Controlled sterilization conditions can be validated to not damage filters
11
g• Post-use integrity failure is not a patient safety
risk• Product is rejected or reworked (per SOP)• Manufacturer’s economic risk only
Rationale againstPost-sterilization / Pre-use IT
• Integrity failure during steaming is typically g y g g yp ydetectable by destructive analysis• Directional over-pressurization at elevated
steaming temperature causes• Core collapse• Cage expansion• Other deformations
12
Ot e de o at o s• Membrane rupture
• Failure to remove air can cause oxidative degradation of the membrane and supports
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
7
“Pore Enlargement Hypothesis”
• Enlarged pore/defect appears during g p pp gsterilization• Potentially large enough for bacterial
penetration• Plugs with contaminant during filtration• Undetectable by post-use integrity test
13
• “False pass” is a patient safety risk• Only a post-sterilization/pre-use integrity
test can detect “pore enlargement”
“Pore Enlargement Hypothesis” basis in EC
• EMEA Inspections - Good Manufacturing Practice - Questions & Answers
• "The filter sterilisation process, may…cause the filter to distort, potentially leading to fluid pathways that allow the passage of particles greater than 0.2µm in size…. For these reasons filters should be tested both, before use but after
14
sterilisation, and again after use.”• Ref: http://www.ema.europa.eu/Inspections/gmp/q15.htm
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
8
“Pore Enlargement Hypothesis” isContradicted by Data
• May occur with obsolete or prototype R&D y p ypmembranes, but
• Does not occur with validated commercial sterilizing grade filter membranes• Filter Validation Guide data• Product-specific validation data
15
• Filter lot release QC test data• Bacterial challenge after autoclaving• Post multiple-autoclaving integrity tests
“Pore Enlargement Hypothesis” isContradicted by Data
• Filters that fail integrity tests after g ysterilization do not “self-repair”
• Non-integral filters cannot be masked by post-use plugging.• Even 0.45 µm filters show very high bacterial
retention efficiencies
16
• Formerly considered “sterilizing grade”
• Single defects in process scale filters must be significantly larger before retention is compromised and filter integrity tests fail.
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
9
Single-use Filtration Systems
17
FDA Guidance for Industry : INDs —Approaches to Complying with CGMPApproaches to Complying with CGMP During Phase 1
“A number of technologies and resources are available for use that can facilitate conformance
with CGMP and help streamline product
18
with CGMP and help streamline product development. Some examples include:
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
10
FDA Guidance for Industry: INDs - Approaches to Complying with CGMP During Phase 1
• Use of disposable equipment and process aids, which can reduce cleaning burden
• Use of presterilized containers can eliminate the need for additional equipment or qualifying existing equipment
• Use of process equipment that is closed (i.e., product not exposed to the environment
19
( p pduring processing), which can alleviate the need for stricter room classification for air quality
Single Use Filtration Systems
20
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
11
Single Use Filtration Systems with Flush Bag for Post-sterilization / Pre-use Integrity Testing
21
Flush Bag
Single Use Filtration Systems with Flush Bag for Post-sterilization / Pre-use Integrity Testing
22
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
12
Single Use Filtration Systems with Flush Bag for Post-sterilization / Pre-use Integrity Testing
23
Integrated Disposable Systems (Manifolds)
Sterile liquid
Waste flush fluid
xSpare outlet
x
xx
Spare inlet
x x xx xx xx
x x
24
flush fluid
Filter
xSample port
Containers to be filled
Sample port
xx x
Sterile storage
container
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
13
Serial / Double / Redundant Filtration
A Short History of Sterilizing Filtration
• Pre-’60’s: Charged depth filters, asbestos filters, porous ceramic filters
• ‘60’s-‘70’s: 0.45 µm membrane filters, cartridges µ , gbubble point testing
• ‘80’s+: 0.2 µm membrane filter cartridges Forward flow (diffusion) testing - 1987 FDA Aseptic Processing Guidelines
• ’90’s+: 0.1 µm membrane filters (enhanced ster’n)Product specific validation
26
Product-specific validation - 1998 PDA Technical Report 26
• ’00’s+: Serial / double / redundant filtration - 2003 EC GMP Annex 1 - 2004 FDA Aseptic Processing Guidance
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
14
Serial / Double / Redundant Filtration
• What does the dictionary say?• Serial: events occurring sequentially• Double: two together or sequentially• Redundant: Superfluous, not needed
What does the dictionary say?
27Ref.s: www.dictionary.com, American Heritage Dictionary
Serial / Double / Redundant Filtration
• What do the regulatory agenciesWhat do the regulatory agencies say?
28
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
15
EMEA Committee for Proprietary p yMedicinal Products (CPMP)Note for Guidance on Manufacture of the Finished Dosage Form (CPMP/QWP/486/95)
29
(CPMP/QWP/486/95)
April, 1996
7. Special Items (1/4)
For sterilisation by filtration the maximum yacceptable bioburden prior to the filtration must be stated in the application.
In most situations NMT 10 CFU’s / 100 ml will be acceptable, depending on the volume to be filtered in relation to the diameter* of the
30
filter. *sic, filter area
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
16
7. Special Items (2/4)
• If this requirement is not met, it is q ,necessary to use a pre-filtration through a bacteria-retaining filter to obtain a sufficiently low bioburden.
31
7. Special Items (3/4)
The type of bacteria-retentive filter and ypits pore size should also be described in the application*. Pore sizes (ratings) of 0.22 µm or less are acceptable without further justification, in accordance with
32
the Ph. Eur.
* Suggests both bioburden filter and sterilizing filter
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
17
7. Special Items (4/4)
A proposal to use a larger pore size in combination with an additional sterilisation step has to be validated and justified in the application file*.
* Use of a larger pore rated bioburden filter may require
33
g p y qadditional bacterial retention validation in addition to validation of the sterilizing filter
EC Guide to GMP - Revision to Annex I - Manufacture of Sterile Medicinal ProductsRevised Feb, 2008
34
Effective March, 2009
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
18
Filtration of medicinal products which cannot be sterilised in their final container
110. If the product cannot be sterilised in the110. If the product cannot be sterilised in the final container, solutions or liquids can be filtered through a sterile filter of nominal pore size of 0.22 micron (or less), or with at least equivalent micro-
35
) qorganism retaining properties, into a previously sterilised container.
Filtration of medicinal products which cannot be sterilised in their final container
111. Due to the potential additional risks of pthe filtration method as compared with other sterilisation processes, a second filtration via a further sterilised micro-organism retaining filter, immediately
i t filli b d i bl Th
36
prior to filling, may be advisable. The final sterile filtration should be carried out as close as possible to the filling point.
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
19
FDA Guidance for Industry –Sterile Drug Products Produced bySterile Drug Products Produced by Aseptic Processing – Current Good Manufacturing Practice, September, 2004
“Use of redundant sterilizing filters
37
should be considered in many cases.”
Redundant FiltrationWhat does industry say?
• Redundant Filtration• A type of serial filtration where a second
sterilizing filter is used as a backup in the event of an integrity failure of the primary sterilizing filter*
38
* PDA Technical Report 26, Sterilizing Filtration of Liquids (2008 Revision, in press), Glossary
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
20
PDA TR26 (rev 2008)7.6.1 Serial Filtration
• If one filter has been validated to achieve sterilization with a specific product• It must satisfactorily pass integrity testing after use
• Where serial filtration is required and has been validated for sterilization of a specific product• The filter train is considered to be the sterilizing unit • All sterilizing grade filters within it must satisfactorily
f
39
pass integrity testing after use
PDA TR26 (rev 2008)7.6.1 Serial Filtration
• It may be difficult to conduct pre-use y pintegrity tests of both filters in a series after sterilization • Sterility downstream of the first filter may
be compromised in testing the second filter
40
filter• Contact filter manufacturers for
recommendations
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
21
PDA TR26 (rev 2008)7.6.1 Serial Filtration
• Redundant filtration• An additional sterilizing-grade filter is placed in
the filter train to ensure against loss of product• Applies if integrity failure of the primary sterilizing filter
• The additional filter does not require post-use integrity testing unless the primary filter fails
• Batch can be released as sterile if the second
41
Batch can be released as sterile if the second (redundant) filter passes integrity testing post-use
• The primary filter is at the distal end of the filtration train
PDA TR26 (rev 2008)7.6.1 Serial Filtration
• For processes requiring in-series integrity testing (e.g., where both filters are sterilized in series)• All valves must be completely open during sterilization to
permit steam penetration
• Each filter must be tested individually • Sterility of the fluid pathway between the two
filters may need to be maintained
42
• Precautions can include add’l sterilizing filters to• Vent the integrity test gas from the first filter• Introduce the test gas for integrity testing the second filter
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
22
PDA TR26 (rev 2008)7.6.1 Serial Filtration
• To test the second filterUse valve between the first and second filter• Use valve between the first and second filter
• Closing this valve isolates the second filter from the first
• Attach integrity test hose (gas pressure) to the integrity test port on the second housing
• Close the vent valve (open for test of the first filter)
43
filter) • Test second filter as usual • All steps must be performed aseptically
• The gas used must be filter sterilized to prevent contaminating the connection between the two filters
Filtration Configurations
• Single / Serial• Bioburden Reduction / Sterilizing • Upstream / Downstream• Double / Redundant
44
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
23
1) Single Filter Upstream of Tank & Filler
• AdvantagesSterilizing
filterg• Simple to operate• Leachables diluted in bulk• Steamable in place (SIP• Integrity test (IT) pre-use
T t f t id
Sterile vent filter
Sterile tank
45
• Test from upstream side• Reprocess buk if filter fails IT
• If pre-qualified, per SOP Filling line
1) Single Filter Upstream of Tank & Filler
• DisadvantagesSterilizing
filterg• Less secure in long term
filling• Time and distance to filling
line considered sterility risk factors
• Filter integrity failure results in
Sterile vent filter
Sterile tank
46
• Filter integrity failure results in loss or reprocessing of batch
• Integrity of vent filter must be confirmed
Filling line
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
24
2) Single Filter Downstream of Tank• Advantages
St ili ti d IT f t filtVent filter
• Sterilization and IT of vent filter may not be required
• Filling can start before tank is full
• Filter sterilizable in situ (SIP) or
Sterilizing filter
Low bioburden
47
• Pre-sterilize filter and aseptic or sterile connect
Filling line
• DisadvantagesBioburden may grow in tank
Vent filter
2) Single Filter Downstream of Tank
• Bioburden may grow in tank over long filling times
• Filter should be pre-flushed prior to container filling to reduce leachables and particulates
• or initial filled containers
Sterilizing filter
Low bioburden
48
• or initial filled containers may be discarded
• Filter integrity failure results in loss of filled container batch
Filling line
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
25
Bioburden Filter Upstream Single Filter Downstream
• AdvantagesBi b d i t k t ll d V t
Bioburden filter
• Bioburden in tank controlled during long filling times
• Bioburden filter may not need to be sterilized, flushed or integrity tested
Sterilizing filter
Vent filter
Controlledbioburden
49
• Bioburden filter can be 0.2 µm or 0.45 µm rated
Filling line
Bioburden Filter Upstream Single Filter Downstream
V t
Bioburden filter
• Disadvantages• Final filter should be pre-flushed
• Or initially filled containers may be discarded
Sterilizing filter
Vent filter
Controlledbioburden
50
• Final filter integrity failure results in loss of filled container batch
Filling line
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
26
4) Double Filters Downstream of Tank• Advantages
• Product can be formulationVent filter• Product can be formulation
in tank• Filter B controls bioburden
upstream of sterilizing filter A• Same filter can be used
• Pre use sterility between
AB Sterilizing filter
High bioburden
Bioburden filter
51
• Pre-use sterility between double filters not required
• Vent and bioburden filters may not need to be integrity tested
Filling line
• Disadvantages• High bioburden may
Vent filter
4) Double Filters Downstream of Tank
• High bioburden may limit filling time
• Filters should be pre-flushed• or initially filled containers
may be discarded• Both filters may still need to be
AB Sterilizing filter
High bioburden
Bioburden filter
52
• Both filters may still need to be integrity tested
• Filter A integrity failure results in loss of filled container batch
Filling line
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
27
5) Redundant Filters Downstream of Tank
• AdvantagesP d t f l t d i t k
Vent filter
• Product formulated in tank• Vent filter testing optional• Post-use integrity failure of
one filter may be allowable • If final filter (A) passes post-
AB
Sterilizing filters
Low bioburden
53
use IT, testing of the second filter (B) is not required
• Filled containers can be released
Filling line
• DisadvantagesP t t ili ti / IT
Vent filter
5) Redundant Filters Downstream of Tank
• Post-sterilization/pre-use IT of both filters is complex• Maintain sterility between filters• Additional valve, sterile drain
and air/vent filters required• Difficult to IT add’l filters in situ
AB
Sterilizing filters
Low bioburden
54
• Difficult to IT add l filters in situ• Single use system with side bag also
eliminates drain, easier to use Filling line
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
28
• AdvantagesSterile
Sterilizing filter
6) Redundant Filters Upstream/Downstream
• Same filter can be used• High assurance of sterilization
• Entire system can be SIP’d• Suitable for long term• Filter A integrity failure may
Sterilizing filter
Sterile vent filter
Sterile tank
B
A
55
g y yallow batch release if Filter B passes integrity
Filling line
• DisadvantagesSterile
Sterilizing filter
6) Redundant Filters Upstream/Downstream
• Separate formulation tank• Sterility of entire system must
be validated• Post-sterilization/pre-use IT
of filter A is complex• Maintain sterility between filters
Sterilizing filter
Sterile vent filter
B
A
Sterile tank
56
• Maintain sterility between filters• Additional valve, sterile drain
and air/vent filters required• Difficult to IT add’l filters in situ
Filling line
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
29
7) Double Redundant • Advantages
Fi l filt d d
Sterilizing filter
C Sterile • Final filter redundancy close to filling line
• Meets critical regulatory interpretations
• Suitable for long term use AB
Sterilizing filters
C vent filter
Sterile tank
57
• Filter C and vent may not need to be sterilizing or integrity tested (bioburden reduction only) Filling
line
• DisadvantagesSeparate formulation tank
7) Double Redundant Sterilizing
filterC Sterile • Separate formulation tank
• Post-sterilization/pre-use IT is even more complex• Maintain sterility between filters• Additional valve, sterile drain
and air/vent filters requiredAB
Sterilizing filters
C vent filter
Sterile tank
58
and air/vent filters required• Difficult to IT add’l filters in situ• Single use system with side bag
also eliminates drain, easier to use
Filling line
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
30
Michael MoussourakisTechnical Manager
Thank YouQuestions?
Technical ManagerPall Life Sciences
25 Harbor Park DrivePort Washington NY 11050
(516) 801 [email protected]
References
• EMEA CPMP Note for Guidance on Manufacture of the Finished Dosage Form (CPMP/QWP/486/95) (April, 1996)http://www.emea.europa.eu/pdfs/human/qwp/048695en.pdf
• EC Guide to GMP Revision to Annex I - Manufacture of Sterile Medicinal Products (May, 2003)http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-4/pdfs-en/revan1vol4_3.pdf
• EC Guide to GMP Revision to Annex I - Manufacture of Sterile Medicinal Products (Rev Feb, 2008, impl. Mar, 2009)http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-4/pdfs-en/2008 02 12 gmp annex1 pdf
60
en/2008_02_12_gmp_annex1.pdf
• Twort, C. et al., “GMP and sterile filtration: a review of some practical and regulatory issues,” Eur J Paren. & Pharm. Sciences 13(3): 65-69 (2008)
ISPE Tampa Conference 22-23 February 2010Tampa, Florida, USA
31
References
• FDA Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing: Good Manufacturing Practice, FDA (2004)
htt // fd / d / id /5882f l hthttp://www.fda.gov/cder/guidance/5882fnl.htm• FDA Guidance for Industry: INDs — Approaches to Complying with
CGMP During Phase 1 (2006)http://www.fda.gov/cber/gdlns/indcgmp.htm
• Sterilizing Filtration of Liquids – Technical Report No. 26, PDA (2008, in press)
https://store.pda.org/bookstore/ProductDetails.aspx?productabbreviation=01026• FDA Federal Register Notice: Amendment to the Current Good
Manufacturing Practice Regulations for Finished Pharmaceuticals;
61
Manufacturing Practice Regulations for Finished Pharmaceuticals; Companion Document to the Direct Final Rule (12/4/2007)
http://www.fda.gov/OHRMS/DOCKETS/98fr/E7-23292.pdf